S. Zama et al. / Tetrahedron Letters 54 (2013) 5605–5607
5607
spectroscopy and X-ray crystallographic analysis confirmed the
structures. A key feature of the reactivity of 1 is the ability to easily
replace the halogen atom at C2 via nucleophilic substitution. The
simplicity of the present procedure makes it an interesting alterna-
tive to other approaches.
Me
S
S
N
N
O
2
Acknowledgments
S
Me
S
S
Me
S
N
N
We thank MESRS (Ministère de l’Enseignement Supérieur et de
la Recherche Scientifique) and ATRST (Agence Thématique de
Recherche en sciences et technologie), Algeria, for financial
support.
N
N
O
O
B
A
References and notes
S
Me
S
N
N
O
C
Figure 4. Resonance structures A and B, and ylide character C of compound 2.
bond in compound 1a (1.511(5) Å). The bond lengths of the phenyl
ring and C4–C5 in the imidazole ring were almost unchanged.
The distribution of single and double bonds in the bicyclic
7-methyl-3-(benzoyl)thiazolo[3,2-a]imidazolium-2-
thiolate (2a) was established by analogy with other similar
compound,
structures.7,11
8. General procedure for the synthesis of thiazolo[3,2-a]imidazoles 2: Et3N (2 mL)
was added, under vigorous stirring to a suspension of imidazolium salt 1
(1.0 mmol) and CS2 (1 mL) in CH3CN (5 mL). The mixture was kept at room
temperature for 30 min (monitored by TLC). The product formed was isolated
as a yellow solid by simple filtration using a Büchner funnel and was washed
with 5 mL THF/H2O (1:1) mixture. The filtrate was concentrated under reduced
pressure, H2O (5 mL) was added and the residue was extracted with CHCl3
(3 Â 10 mL). The extracts were collected, washed with H2O (15 mL) and brine
(15 mL), dried over anhydrous Na2SO4, and the solvent evaporated under
vacuum. Purification by silica gel flash column chromatography (EtOAc),
afforded an additional 5–10% of the product. (yield: 64% for 2a), mp = 192 °C.
Selected data for 2a: 1H NMR (250 MHz, DMSO-d6) d 8.20 (d, J = 2.1 Hz, 1H),
7.89 (d, J = 2.1 Hz, 1H), 7.73–7.69 (m, 2H, Ar), 7.51–7.34 (m, 3H, Ar), (3.96, 3H,
N–CH3); 13C NMR (62.9 MHz, DMSO-d6) d 184.6 (C@O), 173.4 (C), 139.3 (C),
138.9 (C), 131.5 (CH), 129.3 (2 Â CH), 128.0 (2 Â CH), 126.2 (CH) 119.6 (C),
116.8 (CH), 35.7 (N–CH3).
The crystallographic structure of compound 2a shows that the
new heterocyclic compound possesses a bicyclic skeleton with
fused thiazole-imidazolium rings. The bicyclic thiazolo[3,2-a]imid-
azole fragment is approximately planar and forms a dihedral angle
of a 59.16(5)° with the phenyl ring. The carbonyl group is twisted
by 53.11(9)° with respect to the benzene ring. Consequently, the
carbonyl group is not conjugated with the phenyl fragment.
In the thiazole fragment, the C2–S1 bond (1.710(3) Å) is shorter
than the C8–S1 bond (1.804(2) Å), which indicates the electron
delocalization in the thiazole ring. The C2–S1 bond is conjugated
with the lone electron pair of the bridging nitrogen atom N2,
whereas the C8–S1 bond is not affected by any conjugation.
Therefore, it is more correct to view the structure of 2 as a
combination of the two resonance contributors A and B with
alternating single and double bonds. Thus, the delocalization takes
place between N2+@C2–S1 and N2–C2@S1+fragments of the five-
membered ring (Fig. 4).
The exocyclic C8–S2 bond has the shortest length (1.673(3) Å)
and has, in fact, pronounced double bond character (Table 2). Thus,
it is incorrect to represent the mesoionic system as a structure with
a single C8–S2 bond and the negative charge on the S2 atom.
Consequently, the ylide character C of compound 2 (Fig. 4) and
the localization of the negative charge on the C6 atom is a more
adequate representation (Fig. 4).
9. Selected data for 1a: 1H NMR (250 MHz, DMSO-d6) d 8.12–8.07 (m, 3H, Ar), 7.96
(s, 1H, Ar), 7.79 (t, J = 7.2 Hz, 1H, Ar), 7.65 (t, J = 7.3 Hz, 2H, Ar), 6.18 (s, 2H, N–
CH2), 3.92 (s, 3H, N–CH3); 13C NMR (62.9 MHz, DMSO-d6) d 190.8 (C@O), 135.3
(C), 133.7 (CH), 129.6 (2 Â CH), 128.0 (2 Â CH), 125.5 (CH), 125.4 (CH), 125.2
(C), 56.6 (N–CH2), 37.6 (N–CH3).
10. Crystal structure analysis for 1a: C12H12Br2N2O, Mr = 360.06 g molÀ1
,
monoclinic, space group
P
21/a, a = 10.1113(7) Å, b = 13.8160(11) Å,
c = 10.4189(8) Å, b = 114.006(4)°, V = 1329.60(17) Å3, Z = 4,
q
c = 1.799 g cmÀ3
,
F(000) = 704, crystal size: 0.54 Â 0.42 Â 0.36 mm. Crystal structure analysis
for 2a: C13H10N2OS2, Mr = 274.35 g molÀ1, monoclinic, space group P 21/a,
a = 7.8709(8) Å,
b = 13.3757(12) Å,
c = 12.0879(13) Å,
b = 106.270(4)°,
V = 1221.6(2) Å3, Z = 4,
q
c = 1.492 g cmÀ3
,
F(000) = 568, crystal size:
0.24 Â 0.07 Â 0.06 mm. Crystallographic data (excluding structure factors) for
these compounds have been deposited at the Cambridge Crystallographic Data
Centre as supplementary publication numbers CCDC 923502 for 1a and CCDC
923503 for 2a. These data can be obtained free of charge from The Cambridge
In conclusion, we have found that 1-methyl-2-bromoimidazoli-
um salts bearing a –CH2COAr, –CH2COMe, –CH2COOMe, or –CH2CN
fragment at the quaternary nitrogen, react with carbon disulfide in
the presence of Et3N at room temperature to form a previously
unknown class of thiazolo[3,2-a]imidazoles. 1H and 13C NMR